Lindbrook Capital, LLC Bristol Myers Squibb CO Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lindbrook Capital, LLC holds 11,161 shares of BMY stock, worth $643,766. This represents 0.05% of its overall portfolio holdings.

Number of Shares

11,161

Previous 7,837 42.41%

Holding current value

$643,766

Previous $325,000 77.54%

% of portfolio

0.05%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$39.66 - $51.75 $131,829 - $172,017	3,324 Added 42.41%	11,161 $577,000
Q2 2024 Jul 31, 2024	SELL	$40.25 - $52.99 $48,420 - $63,746	-1,203 Reduced 13.31%	7,837 $325,000
Q1 2024 Apr 25, 2024	SELL	$47.98 - $54.4 $19,000 - $21,542	-396 Reduced 4.2%	9,040 $490,000
Q4 2023 Jan 31, 2024	BUY	$48.48 - $57.85 $66,708 - $79,601	1,376 Added 17.07%	9,436 $484,000
Q3 2023 Oct 25, 2023	BUY	$57.89 - $64.73 $10,535 - $11,780	182 Added 2.31%	8,060 $467,000
Q2 2023 Jul 28, 2023	SELL	$63.71 - $70.74 $46,189 - $51,286	-725 Reduced 8.43%	7,878 $503,000
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $43,500 - $49,338	-662 Reduced 7.15%	8,603 $596,000
Q4 2022 Jan 24, 2023	SELL	$68.48 - $81.09 $30,747 - $36,409	-449 Reduced 4.62%	9,265 $0
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $291 - $172,582	2,246 Added 30.07%	9,714 $691,000
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $137,905 - $151,882	-1,899 Reduced 20.27%	7,468 $575,000
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $14,509 - $17,397	-236 Reduced 2.46%	9,367 $684,000
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $110,156 - $128,416	2,054 Added 27.21%	9,603 $599,000
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $12,070 - $14,139	-204 Reduced 2.63%	7,549 $447,000
Q2 2021 Jul 27, 2021	SELL	$61.91 - $67.42 $59,309 - $64,588	-958 Reduced 11.0%	7,753 $518,000
Q1 2021 Apr 28, 2021	BUY	$59.34 - $66.74 $6,290 - $7,074	106 Added 1.23%	8,711 $550,000
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $127,663 - $144,665	2,211 Added 34.58%	8,605 $534,000
Q3 2020 Nov 03, 2020	BUY	$57.43 - $63.64 $18,033 - $19,982	314 Added 5.16%	6,394 $385,000
Q2 2020 Jul 27, 2020	BUY	$54.82 - $64.09 $5,098 - $5,960	93 Added 1.55%	6,080 $358,000
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $44,265 - $64,328	-954 Reduced 13.74%	5,987 $334,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $46,601 - $60,787	947 Added 15.8%	6,941 $446,000
Q3 2019 Oct 31, 2019	SELL	$42.77 - $50.71 $12,018 - $14,249	-281 Reduced 4.48%	5,994 $304,000
Q2 2019 Jul 24, 2019	BUY	$44.62 - $49.34 $50,108 - $55,408	1,123 Added 21.8%	6,275 $284,000
Q1 2019 Apr 23, 2019	BUY	$45.12 - $53.8 $49,406 - $58,911	1,095 Added 26.99%	5,152 $245,000
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $197,819 - $256,524	4,057 New	4,057 $210,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Bristol Myers Squibb CO Transaction History